Oxcarbazepine
The active substance of Oxepilax is oxcarbazepine.
Oxepilax belongs to a group of antiepileptic medicines.
Medicines like Oxepilax are used to treat epileptic seizures.
Patients diagnosed with epilepsy have recurring seizures and convulsions.
These seizures occur due to temporary uncontrolled electrical activity in the brain.
Normally functioning brain cells coordinate body movements by sending organized signals through nerves to muscles. In epilepsy, brain cells send too many signals in an irregular rhythm. This can result in uncoordinated muscle activity, known as epilepsy.
Oxepilax is indicated for the treatment of partial seizures with or without secondary generalized tonic-clonic seizures. Partial seizures involve a limited area of the brain but can spread to the entire brain and may cause generalized tonic-clonic seizures. There are two types of partial seizures: simple and complex. In simple partial seizures, the patient remains conscious, and in complex partial seizures, the patient's consciousness is impaired.
The action of Oxepilax is to inhibit "overexcited" brain cells.
This helps to prevent or reduce the frequency of similar seizures.
Oxepilax can be used as monotherapy (as the only medicine) or in combination with other antiepileptic medicines.
Usually, the doctor tries to find the most suitable medicine for the patient. However, for patients with severe disorders, it may be necessary to take two or more medicines to control seizures.
Oxepilax can be used in adults and children aged 6 years and older.
If the patient has questions about how Oxepilax works and why it has been prescribed, they should consult their doctor.
Follow the doctor's instructions, even if they differ from the information in this leaflet.
Before and during treatment with Oxepilax, the doctor may perform blood tests to determine the correct dose of the medicine for the patient. The doctor will inform when such tests should be performed.
If this applies to the patient, they should inform their doctor before taking Oxepilax. If the patient thinks they may be allergic, they should ask their doctor for advice.
In patients of Chinese Han population and Thai population, there is a risk of severe skin reactions associated with carbamazepine or substances with a similar chemical structure, which can be predicted by a blood test. The doctor should advise the patient whether such tests are necessary before starting oxcarbazepine.
In children, the doctor may recommend monitoring thyroid function before and during treatment.
Tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
This is especially important for:
Oxepilax can be taken with or without food.
Alcohol may enhance the sedative effect of Oxepilax. You should avoid drinking alcohol during treatment and consult your doctor.
Pregnancy
If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medicine.
It is essential to control epileptic seizures during pregnancy. However, taking antiepileptic medicines during pregnancy poses a risk to the baby.
Congenital malformations
Studies have not shown an increased risk of congenital malformations associated with oxcarbazepine use during pregnancy. However, it is impossible to rule out the risk of congenital malformations in the unborn baby.
Developmental disorders of the nervous system
Some studies have shown that exposure to oxcarbazepine in the womb may negatively affect brain development (nervous system development) in children, while other studies have not shown such an effect. It is impossible to rule out the possibility of an impact on nervous system development.
Your doctor will inform you about the benefits and risks of taking Oxepilax and help you decide whether to take the medicine.
Do not stop taking Oxepilax during pregnancy without consulting your doctor.
Before taking any medicine during pregnancy, consult your doctor or pharmacist.
Breastfeeding
If you are breastfeeding, consult your doctor before starting Oxepilax.
The active substance of Oxepilax passes into breast milk. Although available data suggest that the amount of Oxepilax that passes into the baby's body is small, it is impossible to rule out the risk of side effects in the baby. Your doctor will discuss the benefits and risks of breastfeeding while taking Oxepilax. If you are breastfeeding while taking Oxepilax and notice any side effects in your baby, such as excessive sleepiness or poor weight gain, you should inform your doctor immediately.
Oxepilax may cause drowsiness, dizziness, blurred vision, double vision, lack of muscle coordination, or reduced consciousness, especially when starting treatment or increasing the dose.
It is essential to consult your doctor about whether you can drive or operate machinery while taking Oxepilax.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are unsure, consult your doctor or pharmacist.
Oxepilax can be used in children aged 6 years and older.
The dose used in children depends on their body weight.
Take Oxepilax twice a day, every day, at approximately the same times, unless your doctor advises otherwise. This will help best control epilepsy. It will also help you remember when to take the tablet.
Your doctor will inform you how long the treatment with Oxepilax will last. The duration of treatment depends on the type of seizures. It may be necessary to take the medicine for several years to control seizures. Do not change the dose or stop treatment without consulting your doctor.
If you have taken a higher dose of Oxepilax than recommended, you should immediately consult your doctor or the nearest hospital. Symptoms of overdose with Oxepilax include:
If you miss a dose, take it as soon as possible, unless it is almost time for the next dose. Return to your regular dosing schedule. Do not take a double dose to make up for the missed dose.
If you have any doubts or have missed several consecutive doses, consult your doctor.
Do not stop taking Oxepilax unless your doctor advises you to do so.
To avoid a sudden increase in seizures, do not stop taking the medicine abruptly.
If treatment needs to be stopped, it should be done gradually, following your doctor's instructions.
If you have any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, Oxepilax can cause side effects, although not everybody gets them.
The following are signs of potentially serious side effects that may require medical attention. Your doctor will also decide whether to stop taking Oxepilax and how to continue treatment.
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Your doctor will decide whether to stop taking Oxepilax and what further medical care is necessary.
Common(may affect up to 1 in 10 people):
Very rare(may affect up to 1 in 10,000 people):
As soon as possible.Additional medical care may be necessary.
These are usually mild to moderate side effects of Oxepilax. Most of these side effects are temporary and will resolve on their own over time.
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw, phone: 22 49 21 301, fax: 22 49 21 309, website:
https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister pack and carton. The expiry date refers to the last day of the month.
There are no special precautions for storing the medicinal product.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Oxepilax, 300 mg, tablets are: elongated, light pink tablets with a score line on one side and the marking "3" on the other side.
Oxepilax, 600 mg, tablets are: elongated, light pink tablets with a score line on one side and the marking "6" on the other side.
The tablets are available in blisters containing 50 tablets.
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
Atlantic Pharma – Produções Farmacêuticas, S.A.
Rua da Tapada Grande nº 2, Abrunheira
2710-089 Sintra
Portugal
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
Medinfar Manufacturing, S.A.
Parque Industrial Armando Martins Tavares
Rua Outeiro da Armada Nº 5
3150-194 Condeixa-a-Nova
Portugal
Poland
Oxepilax
Date of last revision of the leaflet:07.2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.